Cargando…

Characterization of right ventricular low voltage areas in patients with arrhythmogenic right ventricular cardiomyopathy

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by fibrofatty replacement in the myocardium progressing from the epicardium towards the endocardium and affecting primarily the right ventricle (RV). Little da...

Descripción completa

Detalles Bibliográficos
Autores principales: Bialobroda, J, Badenco, N, Duthoit, G, Waintraub, X, Charpentier, E, Kachenoura, N, Redheuil, A, Gandjbakhch, E, Laredo, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207298/
http://dx.doi.org/10.1093/europace/euad122.264
_version_ 1785046421578186752
author Bialobroda, J
Badenco, N
Duthoit, G
Waintraub, X
Charpentier, E
Kachenoura, N
Redheuil, A
Gandjbakhch, E
Laredo, M
author_facet Bialobroda, J
Badenco, N
Duthoit, G
Waintraub, X
Charpentier, E
Kachenoura, N
Redheuil, A
Gandjbakhch, E
Laredo, M
author_sort Bialobroda, J
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by fibrofatty replacement in the myocardium progressing from the epicardium towards the endocardium and affecting primarily the right ventricle (RV). Little data is available on the distribution of RV electrical abnormalities at the era of epicardial and high-resolution mapping. PURPOSE: To evaluate the extent and distribution of RV epicardial and endocardial low voltage areas and their relationship with ECG abnormalities in ARVC patients. METHODS: Patients with a definite ARVC diagnosis according to the 2020 Task Force Criteria, who underwent ventricular tachycardia ablation between 2016 and 2022 with a high-density RV 3-dimensional electroanatomic mapping, were included. A custom RV segmentation dividing the RV into 10 segments from endocardial maps was used: anterior and lateral right ventricular outflow tract (RVOT); basal and mid inferior wall; apex; septum; basal anterolateral, basal inferolateral, mid anterolateral and mid inferolateral RV free wall (Figure). A standard definition of electrical scar was used (bipolar voltage ≤0.5 mV), and scar areas were manually delineated. Percentage of scar was defined by the ratio between scar area and the total segment area. ECG abnormal findings, such as epsilon wave and T-wave inversion in precordial leads, were measured before ablation procedure. RESULTS: Twenty-nine consecutive definite ARVC patients were included, among whose 24 had epicardial mapping in addition to endocardial mapping. When considering all segments, the epicardial scar (median:70%, interquartile range [IQR] 37-97%) was larger (p<0.0001) than the endocardial scar (9% [IQR] 0-32%). The higher percentage of epicardial scar was found in the basal inferolateral (100% [IQR] 73-100%), basal anterolateral (94% [IQR] 67-100%), RV free wall and lateral RVOT (89% [IQR] 48-100%) segments (Table). Transmural scar was observed mostly in basal inferolateral RV free wall (10 patients, 41%) and basal inferior wall (8 patients, 33%). Patients with major depolarization criteria had a higher percentage of epicardial and endocardial scar as compared to those with no or minor depolarization criteria (respectively 93% [IQR] 59-100% versus 62% [IQR] 28-89%, p<0.0001 and 17% [IQR] 0-42% versus 4% [IQR] 0-23%, p=0.001). There was no significant difference of the percentage of epicardial or endocardial scar in patients with and without major repolarization criteria (respectively 90% [IQR] 49-98% versus 84% [IQR] 43-100%, p=0.91 and 14% [IQR] 11-35% versus 16% [IQR] 0-41%, p=0.73). CONCLUSION: In ARVC, the electrical abnormalities predominate in the basal epicardium. Patients with major depolarization criteria had a higher extent of epicardial and endocardial scar, but there was an association between scar extent and repolarization abnormalities. [Figure: see text] [Figure: see text]
format Online
Article
Text
id pubmed-10207298
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102072982023-05-25 Characterization of right ventricular low voltage areas in patients with arrhythmogenic right ventricular cardiomyopathy Bialobroda, J Badenco, N Duthoit, G Waintraub, X Charpentier, E Kachenoura, N Redheuil, A Gandjbakhch, E Laredo, M Europace 13.1 - Pathophysiology and Mechanisms FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by fibrofatty replacement in the myocardium progressing from the epicardium towards the endocardium and affecting primarily the right ventricle (RV). Little data is available on the distribution of RV electrical abnormalities at the era of epicardial and high-resolution mapping. PURPOSE: To evaluate the extent and distribution of RV epicardial and endocardial low voltage areas and their relationship with ECG abnormalities in ARVC patients. METHODS: Patients with a definite ARVC diagnosis according to the 2020 Task Force Criteria, who underwent ventricular tachycardia ablation between 2016 and 2022 with a high-density RV 3-dimensional electroanatomic mapping, were included. A custom RV segmentation dividing the RV into 10 segments from endocardial maps was used: anterior and lateral right ventricular outflow tract (RVOT); basal and mid inferior wall; apex; septum; basal anterolateral, basal inferolateral, mid anterolateral and mid inferolateral RV free wall (Figure). A standard definition of electrical scar was used (bipolar voltage ≤0.5 mV), and scar areas were manually delineated. Percentage of scar was defined by the ratio between scar area and the total segment area. ECG abnormal findings, such as epsilon wave and T-wave inversion in precordial leads, were measured before ablation procedure. RESULTS: Twenty-nine consecutive definite ARVC patients were included, among whose 24 had epicardial mapping in addition to endocardial mapping. When considering all segments, the epicardial scar (median:70%, interquartile range [IQR] 37-97%) was larger (p<0.0001) than the endocardial scar (9% [IQR] 0-32%). The higher percentage of epicardial scar was found in the basal inferolateral (100% [IQR] 73-100%), basal anterolateral (94% [IQR] 67-100%), RV free wall and lateral RVOT (89% [IQR] 48-100%) segments (Table). Transmural scar was observed mostly in basal inferolateral RV free wall (10 patients, 41%) and basal inferior wall (8 patients, 33%). Patients with major depolarization criteria had a higher percentage of epicardial and endocardial scar as compared to those with no or minor depolarization criteria (respectively 93% [IQR] 59-100% versus 62% [IQR] 28-89%, p<0.0001 and 17% [IQR] 0-42% versus 4% [IQR] 0-23%, p=0.001). There was no significant difference of the percentage of epicardial or endocardial scar in patients with and without major repolarization criteria (respectively 90% [IQR] 49-98% versus 84% [IQR] 43-100%, p=0.91 and 14% [IQR] 11-35% versus 16% [IQR] 0-41%, p=0.73). CONCLUSION: In ARVC, the electrical abnormalities predominate in the basal epicardium. Patients with major depolarization criteria had a higher extent of epicardial and endocardial scar, but there was an association between scar extent and repolarization abnormalities. [Figure: see text] [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10207298/ http://dx.doi.org/10.1093/europace/euad122.264 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 13.1 - Pathophysiology and Mechanisms
Bialobroda, J
Badenco, N
Duthoit, G
Waintraub, X
Charpentier, E
Kachenoura, N
Redheuil, A
Gandjbakhch, E
Laredo, M
Characterization of right ventricular low voltage areas in patients with arrhythmogenic right ventricular cardiomyopathy
title Characterization of right ventricular low voltage areas in patients with arrhythmogenic right ventricular cardiomyopathy
title_full Characterization of right ventricular low voltage areas in patients with arrhythmogenic right ventricular cardiomyopathy
title_fullStr Characterization of right ventricular low voltage areas in patients with arrhythmogenic right ventricular cardiomyopathy
title_full_unstemmed Characterization of right ventricular low voltage areas in patients with arrhythmogenic right ventricular cardiomyopathy
title_short Characterization of right ventricular low voltage areas in patients with arrhythmogenic right ventricular cardiomyopathy
title_sort characterization of right ventricular low voltage areas in patients with arrhythmogenic right ventricular cardiomyopathy
topic 13.1 - Pathophysiology and Mechanisms
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207298/
http://dx.doi.org/10.1093/europace/euad122.264
work_keys_str_mv AT bialobrodaj characterizationofrightventricularlowvoltageareasinpatientswitharrhythmogenicrightventricularcardiomyopathy
AT badencon characterizationofrightventricularlowvoltageareasinpatientswitharrhythmogenicrightventricularcardiomyopathy
AT duthoitg characterizationofrightventricularlowvoltageareasinpatientswitharrhythmogenicrightventricularcardiomyopathy
AT waintraubx characterizationofrightventricularlowvoltageareasinpatientswitharrhythmogenicrightventricularcardiomyopathy
AT charpentiere characterizationofrightventricularlowvoltageareasinpatientswitharrhythmogenicrightventricularcardiomyopathy
AT kachenouran characterizationofrightventricularlowvoltageareasinpatientswitharrhythmogenicrightventricularcardiomyopathy
AT redheuila characterizationofrightventricularlowvoltageareasinpatientswitharrhythmogenicrightventricularcardiomyopathy
AT gandjbakhche characterizationofrightventricularlowvoltageareasinpatientswitharrhythmogenicrightventricularcardiomyopathy
AT laredom characterizationofrightventricularlowvoltageareasinpatientswitharrhythmogenicrightventricularcardiomyopathy